Novel Fluorescence-based Imaging Method for Slide-free Nondestructive Primary Pathology Diagnosis
August 30, 2023
Histolix Appoints Jane Elizabeth Brock, MBBS, Ph.D. to Board of Directors
August 22, 2023
A Pilot Validation Study Comparing Fluorescence-Imitating Brightfield Imaging, A Slide-Free Imaging Method, With Standard Formalin-Fixed, Paraffin-Embedded Hematoxylin-Eosin-Stained Tissue Section Histology for Primary Surgical Pathology Diagnosis
May 23, 2023
Histolix Launches Direct-to-Digital Pathology Read Diagnostic Equivalency Clinical Trial
October 17, 2021